HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $22
HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $22
HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $20 to $22.
HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $20 to $22.